Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

An overview of women’s health in 2024

| Reproductive health, abortion, fertility, reproductive health, women's health

Betsy Goodfellow from Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere …

Feature

Measles: the UK’s next epidemic?

| MMR, measles, vaccines

Recently, the UK has seen a rapid increase in the number of cases of measles, along with a drop in …

Feature

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Business Services |

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Feature
Case study

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

|

Timeline On the 8 June, we had the pleasure of joining Veeva at their 2022 Life Sciences Summit in Zurich, …

Feature

Appy Days: How the smartphone app is revolutionising mental healthcare

|

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

Feature

Injecting real-world data into every day clinical trials – RWE and RWD

|

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Feature

Preparation Preconditions: What measures are needed to combat another pandemic?

|

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Feature

Shaping the new frontiers of women’s health

|

 March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …

Feature

Technology on trial – the latest cogs in the clinical machine

|

From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …

Feature

Access denied: Is Brexit spelling bedlam for UK clinical trials?

|

Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …

Feature

Maintaining product authenticity: The solution to a serial problem

Sales and Marketing |

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Feature

Sidelined or streamlined? Diabetic care and COVID-19

Sales and Marketing |

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

Feature

Outsourcing in clinical trials: A response to rising challenges

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Feature

Debunking vaccine myths and growing concerns

Manufacturing and Production |

Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025